Medifast Inc.

NYSE: MED · Real-Time Price · USD
13.23
0.20 (1.53%)
At close: Aug 15, 2025, 12:05 PM

Medifast Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
2.48M -772K 801K 1.13M -8.15M 8.32M 6.04M 23.13M 30.28M 39.97M 26.52M 36.16M 39.11M 41.78M 34.02M 41.98M 46.96M 41.06M
Depreciation & Amortization
4.04M 3.28M 3.19M 3.19M 3.07M 4.37M 3.35M 3.41M 3.37M 2.97M 2.95M 2.85M 2.73M 2.44M -463K 2.63M 2.63M 2.01M
Stock-Based Compensation
2.63M 1.93M 2.13M 606K 2.45M 2.17M 2.39M 2.67M 2.51M 606K 2.95M 2.96M 2.87M 2.27M 3.29M 2.27M 2.15M 2.2M
Other Working Capital
-6.89M 1.17M 8.67M 6.01M -4.14M 2.54M -12.54M -1.19M -12.83M 18.28M -11.42M 1.95M -34.54M 4.47M 4.75M 2.72M 2.68M -832K
Other Non-Cash Items
-1.68M -1.05M 1.33M 2.86M 22.22M 15.88M 1.31M 1.02M 1.15M 1.37M 3.49M 4.74M 3K 1.63M 5.09M 21K 21K 28K
Deferred Income Tax
-20K 20K -7.52M 106K -103K 112K 6.71M -6.3M 619K 800K 822K -4.96M 1.59M 1.62M -3.71M n/a n/a n/a
Change in Working Capital
-10.83M n/a -4.88M 1.18M -984K -5.06M -9.27M 5.99M 5.22M 18.34M 15.01M 13.64M -2.54M -4.46M -45.68M -31.11M -30.88M 20.02M
Operating Cash Flow
-3.38M 3.41M -4.95M 9.07M 13.07M 7.28M 10.52M 29.93M 43.15M 64.06M 51.74M 55.4M 43.76M 43.67M -7.46M 15.8M 20.88M 65.33M
Capital Expenditures
-1.38M -1.52M -2.29M -1.39M -1.94M -1.84M -946K -1.68M -1.74M -2.12M -9.06M -1.77M -2.84M -3.01M -11.62M -10.39M -7.6M -4.6M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-16.07M -14.99M -22.24M -6.71M -8.48M -9.17M -9.79M -44.78M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
30.81M 14.45M 5.1M 6.23M 7.88M 8.23M n/a n/a n/a n/a n/a n/a 4.02M 1.25M n/a n/a 1.43M 3.72M
Other Investing Acitivies
n/a 7K n/a 82K -594K -934K -9.79M -44.78M n/a n/a n/a n/a 4.02M 1.25M n/a n/a 1.43M 3.72M
Investing Cash Flow
13.36M -2.05M -19.43M -1.78M -2.53M -2.77M -10.73M -46.46M -1.74M -2.12M -9.06M -1.77M 1.18M -1.76M -11.62M -10.39M -6.17M -878K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 27M n/a n/a n/a n/a n/a
Common Stock Repurchased
-1K -369K -1K -2K -16K -817K -10K -110K -2K -6.84M -6.41M -25K -110.07M -11.46M -14.22M -26.3M -12.26M -9.31M
Dividend Paid
-1K -194K n/a -1K -4K -710K -17.98M -18.04M -17.83M -19.16M -17.92M -18.08M -18.96M -16.66M -17.01M -16.75M -16.7M -13.39M
Other Financial Acitivies
n/a -369K n/a n/a n/a 36K 83K n/a n/a 105K n/a -27M n/a n/a n/a 109K 221K 481K
Financial Cash Flow
-2K -563K -1K -3K -20K -1.49M -17.91M -18.15M -17.84M -25.9M -24.33M -45.11M -102.03M -28.12M -31.23M -42.95M -28.74M -22.22M
Net Cash Flow
9.98M 789K -24.38M 7.29M 10.54M 3.03M -18.31M -34.65M 23.66M 36.06M 17.98M 8.64M -56.93M 13.82M -50.33M -37.47M -14.04M 42.31M
Free Cash Flow
-4.76M 1.88M -7.23M 7.68M 11.13M 5.44M 9.58M 28.25M 41.4M 61.94M 42.67M 53.63M 40.92M 40.66M -19.08M 5.41M 13.28M 60.73M